Changing how people interpret threats to help reduce anxiety in movement disorders
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders
This study is testing a friendly online program designed to help people with movement disorders like Huntington's and Parkinson's manage their anxiety by teaching them to think about tricky situations in a more positive way.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10932105 on NIH RePORTER |
What this research studies
This research focuses on developing a web-based intervention to help individuals with neurodegenerative movement disorders, such as Huntington's disease and Parkinson's disease, manage anxiety symptoms. The approach involves cognitive bias modification, which trains participants to reinterpret ambiguous situations in a less threatening way. By addressing negative thought patterns, the goal is to make anxious thinking more flexible and manageable. The research aims to adapt existing programs specifically for individuals with movement disorders, ensuring they meet their unique needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are diagnosed with Huntington's disease or Parkinson's disease and experience anxiety symptoms.
Not a fit: Patients who do not have neurodegenerative movement disorders or those without anxiety symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce anxiety symptoms in patients with neurodegenerative movement disorders, improving their overall quality of life.
How similar studies have performed: Preliminary work has shown feasibility for similar cognitive bias modification approaches in this population, indicating potential for success.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Gibson, Jessie Sellers — University of Virginia
- Study coordinator: Gibson, Jessie Sellers
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.